This decommissioned ERA site remains active temporarily to support our final migration steps to https://ualberta.scholaris.ca, ERA's new home. All new collections and items, including Spring 2025 theses, are at that site. For assistance, please contact erahelp@ualberta.ca.
Search
Skip to Search Results- 1Antisense Oligonucleotide
- 1Antisense therapy
- 1Duchenne Muscular Dystrophy
- 1Dysferlinopathy
- 1Exon Skipping
- 1Muscular Dystrophy
-
Fall 2018
The muscular dystrophies are a heterogeneous group of over 30 genetic diseases which are characterized by progressive weakening and deterioration of muscle tissue and which vary with respect to age of onset, pattern of muscle involvement, and severity. To date, no effective therapeutic options...
-
Fall 2016
Spinal muscular atrophy (SMA) is one of the most common autosomal recessive neuromuscular disorders affecting the motor neurons, which usually has an early onset resulting in a rapid progression of muscle weakness, leading to death at a young age. SMA is caused by a homozygous mutation of...